Results 171 to 180 of about 3,379 (229)

Betahistine

Reactions Weekly
semanticscholar   +3 more sources

Effects of Betahistine Metabolites on Frog Ampullar Receptors

Acta Oto-Laryngologica, 2000
Previous studies have demonstrated that betahistine, an histamine-like substance used widely as an anti-vertigo drug, can decrease ampullar receptor resting discharge without affecting their mechanically evoked responses.
Paola Perin, P Valli, E Mira
exaly   +1 more source

Using Betahistine in the Treatment of Patients With Menière’s Disease: A Meta-Analysis With the Current Randomized-Controlled Evidence

Acta Oto-Laryngologica, 2020
Background: Betahistine is used worldwide to treat patients with Menière’s disease. However, despite it being used for decades, diverging opinions on the effect of betahistine on Menière’s symptomatology still exist.
Bjarki Ditlev Djurhuus, Jesper Hvass Schmidt, Louise Devantier   +2 more
exaly   +2 more sources

Betahistine-induced bronchospasm

Allergy, 1996
Betahistine is a cerebral vasodilator structurally related to histamine, which stimulates H1 bronchial and vascular receptors. We report the case of a 28‐year‐old female patient who presented bronchospasm during treatment with betahistine hydrochloride. The prick test was negative. The oral challenge test showed bronchospasm and urticarial lesions.
I, Jiménez, E, Antón, I, Picáns, J, Jerez   +3 more
openaire   +2 more sources

Clinical efficacy of stellate ganglion block combined with betahistine hydrochloride in the treatment of vestibular migraine

Frontiers in Medical Science Research
: In this study, 100 patients with vestibular migraine treated in our hospital from January 2022 to January 2024 were selected and divided into experimental group and control group according to their willingness to treat, with 50 patients in each group ...
Dajing Jiang, Mei Zhang
semanticscholar   +1 more source

Impact of Betahistine along with Canalith Repositioning Maneuvers on Benign Paroxysmal Positional Vertigo in Real-World Settings

Exclusive Real World Evidence Journal
Background: Benign paroxysmal positional vertigo (BPPV) is a vestibular disorder caused by otoconia displacement, leading to episodic vertigo. While Canalith Repositioning Maneuvers (CRMs) are the primary treatment, recurrence and residual dizziness ...
Carlton Pereira, Ashish Sharma, Paras Borse, V. Pal, Prateek Garg, Riddhi A. Nayak, MG Rajiniganth, Chirag Shah   +7 more
semanticscholar   +1 more source

Betahistine in Ménière's disease

The Journal of Laryngology & Otology, 1976
The effects of betahistine hydrochloride (Serc) on the clinical features of Ménière's disease were assessed in two double-blind, placebo-controlled, cross-over clinical studies. The diagnosis was based on a peripheral, fluctuating, recruiting, cochlear (sensorineural) deafness in one or both ears, tinnitus (usually of low tone) and paroxysmal attacks ...
T J, Wilmot, G N, Menon
openaire   +2 more sources

Betahistine

Drug Safety, 2006
Betahistine is a structural analogue of histamine that is prescribed for the treatment of vestibular disorders such as Ménière's disease and the symptomatic treatment of vertigo. It is estimated from sales information that >130 million patients have been exposed to the drug since its registration in 1968. In this review we analyse the safety profile of
Sabine, Jeck-Thole, Wolfgang, Wagner
openaire   +2 more sources

Betahistine/dexamethasone/isosorbide

Reactions Weekly
openaire   +2 more sources

Betahistine for Meniere’s disease

BMJ, 2016
Betahistine is ineffective, patients urgently need better alternatives The publication of a very well constructed randomised controlled trial1 of betahistine (Serc) for Meniere’s disease underlines the lack of evidence for the efficacy of this drug at both low and high doses. What does this mean for current and future users?
Jonny, Harcourt, Stefano, Cosentino
openaire   +2 more sources